ORMP 8-K 2026-09-17

ORAMED PHARMACEUTICALS INC. (ORMP) 8-K dated 2026-09-17 — accession 0001213900-26-100929. This URL is the filing, not the ORMP hub.

ORAMED PHARMACEUTICALS INC. (ORMP) is a biotechnology company listed on US.

ORAMED PHARMACEUTICALS INC. filed a 8-K on 2026-09-17. Accession 0001213900-26-100929.

Cached items: 5.07. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ORMP revenue for 2025-09-30 was $2.0M. Net income was $48.4M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. ORMP currently screens at market cap $87.2M.

Not investment advice. The ORMP SEC hub lists recent forms. The stock page is the research view.